Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Dupixent + UVB Light Therapy for Eczema
Recruiting4 awardsPhase 4
East Windsor, New Jersey
This trial is testing a new medication, dupilumab, given with a type of light therapy, UVB, to people with eczema. It lasts 24 weeks total, with 12 of those being just on the medication, and the other 12 being on the medication and light therapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.